Results 251 to 260 of about 93,087 (311)

What's atypical about human B cells after allogeneic stem cell transplantation? [PDF]

J Leukoc Biol
Bracken SJ, Poe JC, Sarantopoulos S.
europepmc   +1 more source

Age‐Associated Variations in Complete Blood Cell Count Parameters and Derived Indices Among Community‐Dwelling Chinese Older Adults

Journal of Clinical Laboratory Analysis, EarlyView.
This cross‐sectional study analyzed data from 9331 participants aged 24–97 to characterize age‐ and sex‐related physiological trajectories of complete blood cell count (CBC) parameters and derived inflammatory indices. Key findings encompassed age‐related declines in red blood cell and platelet counts, elevations in RDW‐CV indices and monocyte ...
Xiangyi Ma, Na Liu, Xiang Wu, Qiudan Chen, Xiaotong Chen, Qingyu Zhou, Shuying Chen, Yong Lin, Xuefeng Wang   +8 more
wiley   +1 more source

Early allogeneic stem cell transplantation after melphalan-induced aplasia leads to long-term survival in patients with primary refractory AML. [PDF]

Ann Hematol
Söhn C, Schäfer-Eckart K, Wendelin K, Knop S.   +3 more
europepmc   +1 more source

Not Missing the Notch: Detection Challenges of Juxtamembrane NOTCH1 Variant Detection in T‐Cell Acute Lymphoblastic Leukemia

Journal of Clinical Laboratory Analysis, EarlyView.
ABSTRACT Background Activating mutations in NOTCH1 are frequent in T‐cell acute lymphoblastic leukemia (T‐ALL) and, in the absence of alterations in RAS or PTEN, are associated with favorable prognosis. Besides classical heterodimerization and PEST domain mutations, juxtamembrane internal tandem duplications (JME‐ITDs) represent a third class of ...
Francisco Beas, Stephan Hutter, Ferran Balbastre‐Úbeda, Sandra Novoa‐Jáuregui, Maria Gabarrós‐Subirà, Eulalia Genescà, Petri Pölönen, Torsten Haferlach, Andrés Jerez   +8 more
wiley   +1 more source

Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in patients with aplastic anemia undergoing PBSC-only allogeneic stem cell transplantation: a prospective phase II study. [PDF]

Exp Hematol Oncol
Zhang X, Pan L, Zhao Y, Ma R, Zhang L, Zhang Y, Li G, Zhai W, Ma Q, Pang A, Yang D, Feng S, Zhang P, He Y, Qin G, Jiang E, Han M.   +16 more
europepmc   +1 more source

The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation. [PDF]

Bone Marrow Transplant
Franke GN, Ussmann J, Backhaus D, Nicolay NH, Kuhnt T, Nägler F, Jendro J, Vučinić V, Herling M, Schetschorke B, Herling C, Weibl S, Platzbecker U, Metzeler KH, Schwind S, Jentzsch M.   +15 more
europepmc   +1 more source

It takes two to tango: allogeneic stem cell transplantation and FLT3 tyrosine kinase inhibitor therapy. [PDF]

Haematologica
Cornelissen JJ, Versluis J.
europepmc   +1 more source

Cystatin C-based eGFR better predicts renal vancomycin clearance than creatinine-based eGFR in patients with allogeneic stem cell transplantation. [PDF]

Clin Pharmacol Ther
Wansing EA, Wicha SG, Bannas P, Heitkamp A, Dadkhah A, Kröger NM, Molwitz I, Langebrake C.   +7 more
europepmc   +1 more source

Graft-Versus-Leukemia Effect in the Management of Isolated Pancreatic Granulocytic Sarcoma Following Allogeneic Stem Cell Transplantation. [PDF]

Cureus
Kurt R, Aydin Y, Kalayoglu Besisik S.
europepmc   +1 more source

Thyroid Storm Following Alemtuzumab-based Allogeneic Stem Cell Transplantation: A Case Report and Literature Review. [PDF]

Intern Med
Saigusa S, Uchino K, Seki H, Sugita Y, Isaji Y, Iida Y, Shinohara S, Horio T, Murakami S, Mizuno S, Ikegame K, Hanamura I, Mokuno J, Takagi J, Hirano D, Iida H, Nakao S, Takami A.   +17 more
europepmc   +1 more source